Sign in
Prenatal diagnosis using deletion studies in Duchenne muscular dystrophy
Journal article   Peer reviewed

Prenatal diagnosis using deletion studies in Duchenne muscular dystrophy

Marcy C Speer, Margaret A Pericak‐Vance, Larry H Yamaoka, James Koh, Wu‐Yen Hung, Peter C Gaskell, Jeffery M Vance, Richard J Bartlett and Allen D Roses
Prenatal diagnosis, Vol.8(6), pp.427-437
1988-07
PMID: 3211845

Abstract

Deletion Prenatal diagnosis Duchenne muscular dystrophy RFLP Carrier testing
Accurate carrier testing and prenatal diagnosis in Duchenne muscular dystrophy (DMD) families is facilitated when an Xp21 deletion is found to be segregating within a family. We discuss the results of the DNA testing in two families, one in which DNA from affected males was available for study and the other in which no DNA from an affected male was available. Factors complicating the counselling of DMD deletion families are outlined.

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.255 Musculoskeletal Disorders
1.255.628 Duchenne Muscular Dystrophy
Web Of Science research areas
Genetics & Heredity
Obstetrics & Gynecology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details